News: Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

29.10EUR
11:35am EDT
Price Change (% chg)

€0.21 (+0.73%)
Prev Close
€28.89
Open
€29.43
Day's High
€29.43
Day's Low
€28.81
Volume
333,946
Avg. Vol
180,690
52-wk High
€34.60
52-wk Low
€21.03

Search Stocks
Select another date:

Thu, Jul 31 2014

REFILE-UPDATE 2-Grifols' half-year profit disappoints, shares fall sharply

* Company says Q2 result hit by one-offs linked to Novartis diagnostics purchase

REFILE-Spain's Grifols H1 adjusted profit up 25 pct, misses fcasts

MADRID, July 31 - Spanish healthcare firm Grifols said first half adjusted net profit rose 25 percent on Thursday, slightly below analysts' expectations in a Reuters poll and boosted by the purchase of a diagnostics business early this year.

Spain's Grifols Q1 net profit grows 33 percent

May 6 - Spanish pharmaceutical company Grifols , the world's third-largest blood products maker, posted a 32.9 percent rise in first-quarter net profit on Tuesday to 121 million euros ($168 million), boosted by its acquisition of Novartis' transfusion diagnostic business.

Grifols chairman backs Catalan independence movement

MADRID, April 3 - The head of Spain's largest pharmaceutical company, Grifols, on Thursday became one of the first executives of a major corporation to back a Catalan leader seeking a referendum on independence for Catalonia.

Grifols signs 7-yr contract with Japan's Red Cross for $375 mln

MADRID, March 31 - Spanish blood products company Grifols has signed a 7-year, $375-million contract to conduct blood analysis for Japan's Red Cross, the company said in a statement to the stock market regulator on Monday.

India's Lupin to buy eye treatment drugmaker in Mexico

MUMBAI - Lupin Ltd , India's No. 4 drugmaker by revenue, said on Thursday it has agreed to buy eye-treatments maker Laboratorios Grin S.A. De C.V for an undisclosed amount, moving into Mexico's $275 million ophthalmic market.

India's Lupin to buy eye treatment drugmaker in Mexico

MUMBAI, March 27 - Lupin Ltd, India's No. 4 drugmaker by revenue, said on Thursday it has agreed to buy eye-treatments maker Laboratorios Grin S.A. De C.V for an undisclosed amount, moving into Mexico's $275 million ophthalmic market.

Select another date:
Search Stocks